UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000013241 |
|---|---|
| Receipt number | R000015451 |
| Scientific Title | Continued Use of Antithrombotic agents and Risk Factors for Postoperative Bleeding of Endoscopic Submucosal Dissection of Gastric Neoplasms |
| Date of disclosure of the study information | 2014/03/01 |
| Last modified on | 2015/02/24 13:59:02 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Continued Use of Antithrombotic agents and Risk Factors for Postoperative Bleeding of Endoscopic Submucosal Dissection of Gastric Neoplasms
Acronym
Continued Use of Antithrombotic agents and Postoperative Bleeding of Endoscopic Submucosal Dissection
Scientific Title
Continued Use of Antithrombotic agents and Risk Factors for Postoperative Bleeding of Endoscopic Submucosal Dissection of Gastric Neoplasms
Scientific Title:Acronym
Continued Use of Antithrombotic agents and Postoperative Bleeding of Endoscopic Submucosal Dissection
Region
| Japan |
Condition
Condition
Patients who underwent Endoscopic Submucosal Dissection of Gastric Neoplasms
Classification by specialty
| Gastroenterology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To assess whether there was a risk factor when receiving antithrombotic agents for postoperative bleeding associated with gastric ESD.
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
postoperative bleeeding
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with Gastric Neoplasms
Key exclusion criteria
Physicians diagnosed he/she should be excluded.
Target sample size
500
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Makoto Arai |
Organization
Chiba University
Division name
Gastroenterology
Zip code
Address
1-8-1 Inohana, Chuo-ku, Chiba City
TEL
043-226-2083
araim-cib@umin.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Makoto Arai |
Organization
Chiba University Hospital
Division name
Gastroenterology
Zip code
Address
1-8-1 Inohana, Chuo-ku, Chiba City, JAPAN
TEL
043-226-2083
Homepage URL
araim-cib@umin.ac.jp
Sponsor or person
Institute
Chiba Univeristy
Institute
Department
Personal name
Funding Source
Organization
Chiba Univeristy
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 03 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 02 | Month | 24 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 04 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Evaluation of re-bleeding after ESD
Management information
Registered date
| 2014 | Year | 02 | Month | 24 | Day |
Last modified on
| 2015 | Year | 02 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015451
